Cyclobarbital, cyclobarbitol, or cyclobarbitone refer to a barbiturate derivative.[2]

It was available in Russia as a fixed-dose combination of 100mg cyclobarbital and 10mg diazepam under the brand name Reladorm, indicated for the treatment of insomnia, but was discontinued in 2019.

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Breimer DD, Winten MA (March 1976). "Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration". European Journal of Clinical Pharmacology. 09 (5–6): 443–50. doi:10.1007/bf00606563. PMID 989475. S2CID 20271169.
Allikas: https://en.wikipedia.org/wiki/Cyclobarbitone
No tags for this post.